Mercator Medical maintains its strategy focused on the industrial glove sector and this month will launch the last line in the group’s third factory dedicated to it, informed Vice President Monika Żyznowska. She also assessed that the first signs of an increase in glove prices on the market are visible.
“We maintain our strategy to target the industrial glove sector. The third factory, which is practically fully operational, and the last line will be launched at the end of this month, is dedicated to this type of gloves,” Żyznowska said during the press conference.
She emphasized that focusing on the higher-margin specialist gloves market is a good strategy. She also announced that in the next quarter the company may share news about successes in the US.
Referring to repeated questions about the goals of the share buyback and the possible delisting of the company from the WSE, she said: “We are not in talks about taking the company off the stock exchange and the buyback does not fulfill this goal either. The purpose of the buyback is to transfer profits to shareholders,” Żyznowska declared.
The Mercator Medical Group states that it is the leader in Poland and one of the key players in Central and Eastern Europe on the market of disposable medical gloves. It owns a production plant in Thailand. The group operates globally in over 50 countries. In 2013, the company debuted on the Warsaw Stock Exchange. Its consolidated sales revenues reached PLN 1.73 billion in 2021.